Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie C Hasselluhn

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Trends in Cancer|October 30, 2025
The very druggable RAS proteinsMarie C Hasselluhn, Kenneth P Olive
Cell Death & Disease|June 8, 2019
Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progressionMarie C Hasselluhn, Geske E Schmidt, Volker Ellenrieder, et al.
Frontiers in Medicine|December 5, 2018
Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant RecipientsSebastian C B Bremer, Lars Reinhardt, Michael Sobotta, et al.
Cells|December 28, 2019
Stromal Features of the Primary Tumor Are Not Prognostic in Genetically Engineered Mice of Pancreatic CancerMarie C Hasselluhn, Lukas Klein, Melanie S Patzak, et al.
Cancer Research|September 16, 2024
Pancreatic Cancer-Associated Fibroblasts: Where Do We Go from Here?Eileen S Carpenter, Debora Barbosa Vendramini-Costa, Marie C Hasselluhn, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
"Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug"Amanda R Decker-Farrell, Stephen A Sastra, Tetsuhiro Harimoto, et al.
Cancer Discovery|November 15, 2023
Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer AngiosuppressionMarie C Hasselluhn, Amanda R Decker-Farrell, Lukas Vlahos, et al.
Gastroenterology|November 1, 2023
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational TherapiesMarie C Hasselluhn, Denise Schlösser, Lennart Versemann, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaUrszula N Wasko, Jingjing Jiang, Alvaro Curiel-Garcia, et al.
Nature|November 12, 2024
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancerUrszula N Wasko, Jingjing Jiang, Tanner C Dalton, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Trends in Cancer|October 30, 2025
The very druggable RAS proteinsMarie C Hasselluhn, Kenneth P Olive
Cell Death & Disease|June 8, 2019
Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progressionMarie C Hasselluhn, Geske E Schmidt, Volker Ellenrieder, et al.
Frontiers in Medicine|December 5, 2018
Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant RecipientsSebastian C B Bremer, Lars Reinhardt, Michael Sobotta, et al.
Cells|December 28, 2019
Stromal Features of the Primary Tumor Are Not Prognostic in Genetically Engineered Mice of Pancreatic CancerMarie C Hasselluhn, Lukas Klein, Melanie S Patzak, et al.
Cancer Research|September 16, 2024
Pancreatic Cancer-Associated Fibroblasts: Where Do We Go from Here?Eileen S Carpenter, Debora Barbosa Vendramini-Costa, Marie C Hasselluhn, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
"Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug"Amanda R Decker-Farrell, Stephen A Sastra, Tetsuhiro Harimoto, et al.
Cancer Discovery|November 15, 2023
Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer AngiosuppressionMarie C Hasselluhn, Amanda R Decker-Farrell, Lukas Vlahos, et al.
Gastroenterology|November 1, 2023
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational TherapiesMarie C Hasselluhn, Denise Schlösser, Lennart Versemann, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinomaUrszula N Wasko, Jingjing Jiang, Alvaro Curiel-Garcia, et al.
Nature|November 12, 2024
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancerUrszula N Wasko, Jingjing Jiang, Tanner C Dalton, et al.
Pageof 2